Skip to main content
. 2024 Aug 2;14:17877. doi: 10.1038/s41598-024-66488-x

Table 2.

Uncorrelated and significantly differentially methylated CpG sites between paired tumour and adjacent benign diagnostic samples.

CpG Chr Position Gene Gene Region Bonferroni deltaβ
cg11213690 7 149,112,402 Intergenic Intergenic 2.92E−18 0.48
cg06832339 7 23,842,119 STK31 Body 4.19E−18 0.42
cg09414673 7 1,022,797 CYP2W1 TSS200 1.10E−17 0.45
cg05415131 11 58,940,866 DTX4 Body 5.06E−17 0.54
cg26310256 23 13,588,301 EGFL6 Body 1.09E−16 0.52
cg03217795 16 23,847,556 PRKCB 1st Exon 1.17E−16 0.42
cg03225210 7 143,579,951 FAM115A 5'UTR 1.79E−16 0.49
cg16670497 1 110,210,913 GSTM2 Body 2.52E−16 0.54
cg14621217 17 80,944,134 B3GNTL1 Body 6.20E−16 0.45
cg16709294 14 70,235,567 SFRS5; LOC100289511 Body; TSS1500 6.81E−16 0.43
cg21918559 23 36,976,052 Intergenic Intergenic 9.36E−16 0.48
cg14775423 4 57,372,356 ARL9 5'UTR 1.74E−15 0.42
cg14179575 18 13,826,399 MC5R 1st Exon 2.43E−15 0.42
cg05057720 14 38,724,675 CLEC14A 1st Exon 4.26E−15 0.5
cg19713460 22 39,745,530 SYNGR1 TSS1500 6.48E−15 0.44
cg00927554 12 95,941,920 USP44 5'UTR 4.16E−11 0.41